✨ Government Appointment and Medicines Consent
NEW ZEALAND GAZETTE
No. 61
Government Superannuation Fund Act 1956
Reappointment of Chairperson of the Government Superannuation Appeals Board
Pursuant to the Government Superannuation Fund Act 1956, the Minister responsible for the Government Superannuation Fund, the Honourable Dr Michael Cullen, is pleased to announce the reappointment of
Mark Byers
as Chairperson of the Government Superannuation Appeals Board.
The reappointment is for a 3 year term which commenced 1 June 2001.
Dated at Wellington this 1st day of June 2001.
MICHAEL CULLEN, Minister of Finance.
go4057
Health
Medicines Act 1981
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
| Product: | Aquaear drops |
|---|---|
| Active Ingredient(s): | Glacial acetic acid 17.3mg/mL |
| Isopropyl alcohol 634mg/mL | |
| Dosage Form: | Ear drops |
| New Zealand Sponsor: | Whitehall Consumer Healthcare (NZ) Limited |
| Manufacturer(s): | Ensign Laboratories Pty Limited, Mulgrave, Victoria, Australia |
| Product: | Aridine |
|---|---|
| Active Ingredient(s): | Loratadine 10mg/dose |
| Dosage Form: | Tablet |
| New Zealand Sponsor: | Douglas Pharmaceuticals Limited |
| Manufacturer(s): | Delta Limited, Hafnarfjordur, Iceland |
| Product: | Ceftriaxone |
|---|---|
| Active Ingredient(s): | Ceftriaxone sodium 1,193.3mg equivalent to 1000mg ceftriaxone |
| Dosage Form: | Powder for injection |
| New Zealand Sponsor: | Novartis New Zealand Limited |
| Manufacturer(s): | Biochemie GmbH, Kundl, Austria |
| Product: | Ceftriaxone |
|---|---|
| Active Ingredient(s): | Ceftriaxone sodium 2,386.6mg equivalent to 2000mg ceftriaxone |
| Dosage Form: | Powder for injection |
| New Zealand Sponsor: | Novartis New Zealand Limited |
| Manufacturer(s): | Biochemie GmbH, Kundl, Austria |
| Product: | Ceftriaxone |
|---|---|
| Active Ingredient(s): | Ceftriaxone sodium 298.3mg equivalent to 250mg ceftriaxone |
| Dosage Form: | Powder for injection |
| New Zealand Sponsor: | Novartis New Zealand Limited |
| Manufacturer(s): | Biochemie GmbH, Kundl, Austria |
| Product: | Ceftriaxone |
|---|---|
| Active Ingredient(s): | Ceftriaxone sodium 596.7mg equivalent to 500mg ceftriaxone |
| Dosage Form: | Powder for injection |
| New Zealand Sponsor: | Novartis New Zealand Limited |
| Manufacturer(s): | Biochemie GmbH, Kundl, Austria |
| Product: | Chesty Congested Cough |
|---|---|
| Active Ingredient(s): | Opium tincture 16.08mg/mL |
| Squill oxymel 44.4mg/mL | |
| Dosage Form: | Linctus |
| New Zealand Sponsor: | PSM Healthcare Limited |
| Manufacturer(s): | PSM Healthcare Limited, Wiri, Auckland |
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2001, No 61
Gazette.govt.nz —
NZ Gazette 2001, No 61
✨ LLM interpretation of page content
🏛️ Reappointment of Chairperson of the Government Superannuation Appeals Board
🏛️ Governance & Central Administration1 June 2001
Appointments, Government Superannuation Fund, Appeals Board, Chairperson
- Mark Byers, Reappointed as Chairperson of the Government Superannuation Appeals Board
- Honourable Dr Michael Cullen, Minister of Finance
🏥 Consent to the Distribution of New Medicines
🏥 Health & Social WelfareMedicines, Distribution, Consent, New Zealand Sponsor, Manufacturer
- Minister of Health